Copyright © Inderes 2011 - present. All rights reserved.
Log ind for at modtage meddelelser.
  • Latest
  • Markeder
    • Aktieoversigt
    • Finanskalender
    • Research
    • Artikler
  • InderesTV
  • Forum
  • Om os
    • Fulgte selskaber
    • Team

aXichem

7,3SEK +10,61%
Vær den første som følger denne virksomhed
www.axichem.com

aXichem is active in industrial biotechnology. The company develops, patents and markets industrial chemicals. The company mainly works with Phenylcapsaicin, a natural analog synthetic capsaicin with applications in a variety of areas, such as in the marine sector, among pest control in forestry and agriculture, as well as among individual pharmaceutical work areas. Operations are run on a global level, with the head office in Malmö.

Omsætning
5,01 mio.
EBIT %
-290,42 %
P/E
-
Udbytteafkast, %
-
Kursmål
-
Anbefaling
-
Opdateret
-
First North Stockholm
AXIC A
Daglig lav / høj pris
6,62 / 7,3 SEK
Markedsværdi
156,92 mio. SEK
Aktieomsætning
67,86 t SEK
Volumen
9,7 t

Finanskalender

Årsrapport
21.02.2024
Delårsrapport
23.05.2024
Delårsrapport
22.08.2024
Delårsrapport
21.11.2024
Årsrapport
27.02.2025

Major Owners
Source: Millistream Market Data AB

OwnerCapitalVotes
LMK Forward12,2 %11,1 %
Manakin Ltd 9,1 %9,1 %
Premium
Not activated

This content is for our Premium customers only.

Sign inLearn more
ViserAlle indholdstyper
Pressemeddelelse
10.11.2022

Redeye: aXichem - Essential approvals ahead

aXichem

Selskabsmeddelelse
27.10.2021

aXichem AB: aXichem secures production capacity for phenylcapsaicin, corresponding to volumes of up to 100 tons of aXiphen-feed, for the upcoming six to nine months

aXichem

Selskabsmeddelelse
04.10.2021

aXichem AB: aXichem exhibits at Vitafoods Europe 2021 in Geneva, and launches a new website presenting the unique product aXivite

aXichem

Selskabsmeddelelse
13.09.2021

aXichem AB: aXichem exhibits at Vitafoods Europe 2021 in Geneva, presenting its innovative product aXivite, with proven significant effect in decrease of body fat

aXichem

Selskabsmeddelelse
07.09.2021

Redeye: aXichem - Entering the Commercial Phase

aXichem

Selskabsmeddelelse
12.04.2021

aXichem AB: aXichem's product aXivite[®] is the active ingredient in a new pre-workout drink launched on the Spanish market

aXichem

Forbinder investorer og virksomheder

Vores sociale mål er at demokratisere information på de finansielle markeder, så alle har lige muligheder for at investere og spare op til deres egen fremtid.

Tag kontakt
  • mie@hcandersencapital.dk
  • +45 28 74 66 40
  • Bredgade 23B, 2. sal
    1260 København K
  • Om os
  • Servicevilkår
  • Privatlivspolitik
  • Ansvarsfraskrivelse for research
Inderes’ ansvarsfraskrivelse kan findes her. Detaljeret information om hver aktie, der aktivt overvåges af Inderes og HC Andersen Capital, er tilgængelig på de virksomhedsspecifikke sider på Inderes' hjemmeside. © Inderes Oyj. All rights reserved.